Biontech Se ADR (BNTX)

$92.95 +0.50 (0.54%)
Market Cap 23.04B
Revenue (ttm) 3.25B
Net Income (ttm) -1.29B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -39.59%
Debt to Equity Ratio 0.02
Volume 740,100
Avg Vol 923,190
Day's Range N/A - N/A
Shares Out 252.88M
Stochastic %K 73%
Beta 1.32
Analysts Strong Sell
Price Target $126.72

Company Profile

BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin a...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 6131 9084
Fax: 49 6131 9084
Address:
An der Goldgrube 12, Mainz, Germany
taxplanr
taxplanr Jul. 30 at 1:14 AM
Fauci testimony prophecy via Dave Chapelle 🤣🤣🤣 $PFE $MRNA $BNTX https://www.instagram.com/reel/DbYq8cyxbOy/?igsh=MWMyZXRjdmhhYzJnNA==
0 · Reply
Samishere
Samishere Jul. 29 at 2:17 PM
$BNTX
1 · Reply
Meril_Knoxville
Meril_Knoxville Jul. 29 at 9:37 AM
$TTWO $PODD $BNTX $ELS $USB few
0 · Reply
taxplanr
taxplanr Jul. 28 at 7:44 PM
Fauci suffered a pulmonary embolism a few months after his $MRNA jab as per his diary and did not disclose it $PFE $BNTX https://www.instagram.com/reel/DbWGz8PxJMM/?igsh=MWQ5MmIzMjE0dGFtcw==
2 · Reply
Samishere
Samishere Jul. 23 at 5:21 PM
$BNTX True American Hero !
1 · Reply
taxplanr
taxplanr Jul. 23 at 2:09 PM
Spike Protein biology for C19 bioweapons ... And now flu shots pet and livestock vaccines $MRNA $PFE $BNTX https://www.tiktok.com/t/ZTAY7GL2o/
0 · Reply
Ventureville
Ventureville Jul. 22 at 5:39 PM
$BIOV.CSE $BVAXF now has two competing narratives: encouraging Phase 1 platform data and an immediate financial-reporting problem. Resolution of the filing delay is the next catalyst the market needs before the science can be properly valued. $MRNA $BNTX
1 · Reply
DidYouReadThis
DidYouReadThis Jul. 21 at 10:08 PM
$BNTX What's your favorite stock? I like #OTLK #PDUFA 7/29/26
1 · Reply
taxplanr
taxplanr Jul. 21 at 8:24 PM
Special TikTok for $BNTX $MRNA $PFE investors Please share https://www.tiktok.com/t/ZTALmSv8X/
0 · Reply
yus37
yus37 Jul. 21 at 8:22 PM
$IOVA Good recovery here. I hope to see #Iovance back in double digits. I'm no longer holding the stock, but I still have a soft spot for the company. Most importantly, I hope Amtagvi makes a real difference for cancer patients. I may jump back in if I see an attractive dip. Wishing all patients and holders the best. ❤️🙏 $XBI $MRNA $IBRX $BNTX
0 · Reply
Latest News on BNTX
EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

2026-07-29T20:42:19.000Z - 4 hours ago

EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

PFE

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 4 hours ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026

Jul 21, 2026, 6:45 AM EDT - 8 days ago

BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026

BioNTech price target lowered to $119 from $126 at Morgan Stanley

2026-07-08T11:40:53.000Z - 21 days ago

BioNTech price target lowered to $119 from $126 at Morgan Stanley

BioNTech held buyer talks over four German sites set to close, Handelsblatt reports

Jul 3, 2026, 1:51 AM EDT - 26 days ago

BioNTech held buyer talks over four German sites set to close, Handelsblatt reports

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO

Jun 17, 2026, 2:38 AM EDT - 6 weeks ago

Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO

MRNA

BioNTech, Bristol announce interim Phase 2 data from Rosetta Lung-02 trial

2026-05-31T21:45:07.000Z - 2 months ago

BioNTech, Bristol announce interim Phase 2 data from Rosetta Lung-02 trial

BMY

Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

May 30, 2026, 2:15 PM EDT - 2 months ago

Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial

This Biotech's Cancer Portfolio Could End Its Rough Patch

May 27, 2026, 11:07 AM EDT - 2 months ago

This Biotech's Cancer Portfolio Could End Its Rough Patch

BioNTech upgraded to Buy from Neutral at UBS

2026-05-27T08:45:10.000Z - 2 months ago

BioNTech upgraded to Buy from Neutral at UBS

BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting

May 22, 2026, 5:00 AM EDT - 2 months ago

BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting

Bernstein starts BioNTech at Market Perform, sees high registration risk

2026-05-21T21:20:11.000Z - 2 months ago

Bernstein starts BioNTech at Market Perform, sees high registration risk

BioNTech initiated with a Market Perform at Bernstein

2026-05-21T20:27:55.000Z - 2 months ago

BioNTech initiated with a Market Perform at Bernstein

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026

May 15, 2026, 4:15 PM EDT - 2 months ago

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026

BioNTech SE Transcript: AGM 2026

May 15, 2026, 8:00 AM EDT - 2 months ago

BioNTech SE Transcript: AGM 2026

Berenberg cuts BioNTech target, says shares ‘deeply’ undervalued

2026-05-12T08:30:54.000Z - 2 months ago

Berenberg cuts BioNTech target, says shares ‘deeply’ undervalued

BioNTech announces new $1B ADS repurchase program

2026-05-07T14:04:55.000Z - 2 months ago

BioNTech announces new $1B ADS repurchase program

BioNTech Announces New ADS Repurchase Program

May 7, 2026, 6:45 AM EDT - 2 months ago

BioNTech Announces New ADS Repurchase Program

BioNTech price target lowered to $158 from $171 at Canaccord

2026-05-07T07:26:08.000Z - 2 months ago

BioNTech price target lowered to $158 from $171 at Canaccord

Germany says vaccine supply secure despite BioNTech production loss

May 6, 2026, 7:44 AM EDT - 3 months ago

Germany says vaccine supply secure despite BioNTech production loss

BioNTech to cut up to 1,860 jobs, close multiple global sites, Reuters reports

2026-05-05T15:41:20.000Z - 3 months ago

BioNTech to cut up to 1,860 jobs, close multiple global sites, Reuters reports

PFE

BioNTech SE Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

BioNTech SE Earnings Call Transcript: Q1 2026

BioNTech SE Earnings release: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

BioNTech SE Earnings release: Q1 2026

BioNTech SE Slides: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

BioNTech SE Slides: Q1 2026

BioNTech to Close Sites, Cut Quarter of Workforce in Savings Push

May 5, 2026, 7:26 AM EDT - 3 months ago

BioNTech to Close Sites, Cut Quarter of Workforce in Savings Push

BioNTech reaffirms FY26 revenue view EUR2.000B- EUR2.300B

2026-05-05T11:14:49.000Z - 3 months ago

BioNTech reaffirms FY26 revenue view EUR2.000B- EUR2.300B

BioNTech to close sites in Germany, Singapore affecting 1,860 staff

May 5, 2026, 6:47 AM EDT - 3 months ago

BioNTech to close sites in Germany, Singapore affecting 1,860 staff

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update

May 5, 2026, 6:45 AM EDT - 3 months ago

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update

Two experimental drugs showed striking early results against pancreatic cancer

Apr 21, 2026, 5:35 PM EDT - 3 months ago

Two experimental drugs showed striking early results against pancreatic cancer

RVMD

BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026

Apr 21, 2026, 6:45 AM EDT - 3 months ago

BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026

BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

Apr 11, 2026, 7:00 AM EDT - 3 months ago

BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 4 months ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

PFE

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

Mar 24, 2026, 6:45 AM EDT - 4 months ago

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

BioNTech SE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Mar 10, 2026, 2:48 PM EDT - 5 months ago

BioNTech SE Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

One simple reason why BioNTech stock is a raging buy on today's crash

Mar 10, 2026, 1:29 PM EDT - 5 months ago

One simple reason why BioNTech stock is a raging buy on today's crash

BioNTech SE Earnings Call Transcript: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

BioNTech SE Earnings Call Transcript: Q4 2025

BioNTech SE Annual report: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

BioNTech SE Annual report: Q4 2025

BioNTech SE Earnings release: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

BioNTech SE Earnings release: Q4 2025

BioNTech SE Slides: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

BioNTech SE Slides: Q4 2025

Scientists behind COVID-19 vaccine will depart BioNTech

Mar 10, 2026, 7:40 AM EDT - 5 months ago

Scientists behind COVID-19 vaccine will depart BioNTech

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock.

Mar 10, 2026, 7:18 AM EDT - 5 months ago

BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock.

BioNTech Cofounders to Leave to Form New Company

Mar 10, 2026, 6:50 AM EDT - 5 months ago

BioNTech Cofounders to Leave to Form New Company

BioNTech's founding couple Sahin, Tuereci to leave to set up new venture

Mar 10, 2026, 6:49 AM EDT - 5 months ago

BioNTech's founding couple Sahin, Tuereci to leave to set up new venture

BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update

Mar 10, 2026, 6:45 AM EDT - 5 months ago

BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update

BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030

Mar 10, 2026, 6:33 AM EDT - 5 months ago

BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030

BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026

Feb 24, 2026, 6:45 AM EST - 5 months ago

BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026

BioNTech sues Moderna for patent infringement over COVID-19 shots

Feb 19, 2026, 1:25 PM EST - 5 months ago

BioNTech sues Moderna for patent infringement over COVID-19 shots

MRNA

BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer

Jan 28, 2026, 8:00 AM EST - 6 months ago

BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer

BioNTech SE Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 5:15 PM EST - 7 months ago

BioNTech SE Transcript: 44th Annual J.P. Morgan Healthcare Conference

BioNTech SE Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 5:15 PM EST - 7 months ago

BioNTech SE Slides: 44th Annual J.P. Morgan Healthcare Conference

BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 6:45 AM EST - 7 months ago

BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference

University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund

Jan 9, 2026, 10:00 AM EST - 7 months ago

University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

Dec 18, 2025, 4:45 AM EST - 7 months ago

BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

Dec 9, 2025, 7:00 AM EST - 8 months ago

BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer

BMY

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Dec 6, 2025, 3:30 PM EST - 8 months ago

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

Dec 3, 2025, 9:01 AM EST - 8 months ago

BioNTech Achieves Minimum Condition in CureVac Exchange Offer

CVAC

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 8 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

MRNA NVAX PFE

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 8 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

MRNA NVAX PFE

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Nov 26, 2025, 7:30 AM EST - 8 months ago

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

Nov 13, 2025, 5:20 PM EST - 9 months ago

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

PFE

BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025, 8:17 AM EST - 9 months ago

BioNTech says collaboration with Pfizer remains unchanged

PFE

BioNTech SE Transcript: R&D Day

Nov 11, 2025, 9:00 AM EST - 9 months ago

BioNTech SE Transcript: R&D Day

BioNTech SE Slides: R&D Day

Nov 11, 2025, 9:00 AM EST - 9 months ago

BioNTech SE Slides: R&D Day

BioNTech SE Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:00 AM EST - 9 months ago

BioNTech SE Earnings Call Transcript: Q3 2025

BioNTech SE Earnings release: Q3 2025

Nov 3, 2025, 8:00 AM EST - 9 months ago

BioNTech SE Earnings release: Q3 2025

BioNTech SE Slides: Q3 2025

Nov 3, 2025, 8:00 AM EST - 9 months ago

BioNTech SE Slides: Q3 2025

BioNTech lifts 2025 revenue guidance on BMS partnership payment

Nov 3, 2025, 6:47 AM EST - 9 months ago

BioNTech lifts 2025 revenue guidance on BMS partnership payment

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

Nov 3, 2025, 6:45 AM EST - 9 months ago

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Oct 28, 2025, 7:45 AM EDT - 9 months ago

BioNTech to Host Innovation Series R&D Day on November 11, 2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

Oct 27, 2025, 7:45 AM EDT - 9 months ago

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Oct 22, 2025, 6:45 AM EDT - 10 months ago

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

BioNTech SE Transcript: AI Day 2025

Oct 1, 2025, 9:00 AM EDT - 10 months ago

BioNTech SE Transcript: AI Day 2025

BioNTech SE Slides: FY 2025

Oct 1, 2025, 9:00 AM EDT - 10 months ago

BioNTech SE Slides: FY 2025

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Sep 23, 2025, 6:45 AM EDT - 11 months ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 11 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

MRNA NVAX PFE

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

Sep 12, 2025, 1:37 PM EDT - 11 months ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

Sep 8, 2025, 11:05 AM EDT - 11 months ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

BMY

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 11:00 AM EDT - 11 months ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

taxplanr
taxplanr Jul. 30 at 1:14 AM
Fauci testimony prophecy via Dave Chapelle 🤣🤣🤣 $PFE $MRNA $BNTX https://www.instagram.com/reel/DbYq8cyxbOy/?igsh=MWMyZXRjdmhhYzJnNA==
0 · Reply
Samishere
Samishere Jul. 29 at 2:17 PM
$BNTX
1 · Reply
Meril_Knoxville
Meril_Knoxville Jul. 29 at 9:37 AM
$TTWO $PODD $BNTX $ELS $USB few
0 · Reply
taxplanr
taxplanr Jul. 28 at 7:44 PM
Fauci suffered a pulmonary embolism a few months after his $MRNA jab as per his diary and did not disclose it $PFE $BNTX https://www.instagram.com/reel/DbWGz8PxJMM/?igsh=MWQ5MmIzMjE0dGFtcw==
2 · Reply
Samishere
Samishere Jul. 23 at 5:21 PM
$BNTX True American Hero !
1 · Reply
taxplanr
taxplanr Jul. 23 at 2:09 PM
Spike Protein biology for C19 bioweapons ... And now flu shots pet and livestock vaccines $MRNA $PFE $BNTX https://www.tiktok.com/t/ZTAY7GL2o/
0 · Reply
Ventureville
Ventureville Jul. 22 at 5:39 PM
$BIOV.CSE $BVAXF now has two competing narratives: encouraging Phase 1 platform data and an immediate financial-reporting problem. Resolution of the filing delay is the next catalyst the market needs before the science can be properly valued. $MRNA $BNTX
1 · Reply
DidYouReadThis
DidYouReadThis Jul. 21 at 10:08 PM
$BNTX What's your favorite stock? I like #OTLK #PDUFA 7/29/26
1 · Reply
taxplanr
taxplanr Jul. 21 at 8:24 PM
Special TikTok for $BNTX $MRNA $PFE investors Please share https://www.tiktok.com/t/ZTALmSv8X/
0 · Reply
yus37
yus37 Jul. 21 at 8:22 PM
$IOVA Good recovery here. I hope to see #Iovance back in double digits. I'm no longer holding the stock, but I still have a soft spot for the company. Most importantly, I hope Amtagvi makes a real difference for cancer patients. I may jump back in if I see an attractive dip. Wishing all patients and holders the best. ❤️🙏 $XBI $MRNA $IBRX $BNTX
0 · Reply
wheresdannynow
wheresdannynow Jul. 21 at 4:04 PM
$BVAXF Phase 1 results gave $BIOV $BVAXF another clinical validation point for DPX-formulated products. For a platform biotech, reproducible human data matter more than pipeline quantity. $IOVA $MRNA $BNTX
0 · Reply
wheresdannynow
wheresdannynow Jul. 21 at 4:03 PM
$BVAXF The latest clinical update strengthens the scientific case for the DPX platform. $BIOV.CSE now needs regulatory execution, financing clarity and a development partner to unlock that value. $MRNA $BNTX $CVAC
0 · Reply
wheresdannynow
wheresdannynow Jul. 20 at 4:36 PM
$BVAXF The most important catalyst for $BIOV.CSE $BVAXF is not another pipeline announcement. It is clinical evidence showing durable immune activation, tumor response and acceptable safety. $IOVA $MRNA $BNTX
0 · Reply
wheresdannynow
wheresdannynow Jul. 20 at 4:35 PM
$BVAXF Cancer vaccines are not simply about identifying an antigen. The delivery system must sustain immune exposure long enough to produce a meaningful cellular response. That is the technical angle behind $BIOV $BVAXF. $BNTX $MRNA
0 · Reply
wheresdannynow
wheresdannynow Jul. 20 at 4:35 PM
$BVAXF thesis is platform validation. If DPX can consistently generate durable, antigen-specific T-cell responses, the opportunity extends beyond a single cancer indication. $MRNA $BNTX $CVAC
0 · Reply
taxplanr
taxplanr Jul. 18 at 2:25 AM
$BNTX $MRNA $PFE answer https://www.instagram.com/reel/DayezoTRvv3/?igsh=cXdqbXR6NjA3dDZv
0 · Reply
Davidendz
Davidendz Jul. 17 at 2:25 PM
$BVAXF Cancer vaccines have historically struggled with weak or short-lived immune activation. The $BIOV $BVAXF thesis rests on whether DPX can generate persistent, therapeutically relevant T-cell responses. $BNTX $MRNA $CVAC
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 16 at 6:41 PM
ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection? $ABUS $MRNA $PFE $BNTX https://stocktwits.com/news/equity/markets/abus-stock-on-track-for-best-day-in-about-two-months-what-s-the-moderna-connection/cZZEkhNR7sx
0 · Reply
eightytwentie
eightytwentie Jul. 14 at 9:57 PM
$BNTX up $6 after hours Yeah baby
3 · Reply
Nitroxic73
Nitroxic73 Jul. 14 at 1:24 PM
$BNTX You can bet your house what will happen today… they buy up to a 90.50-91.50 price level and then let it melt into the afternoon. 😂
1 · Reply
Nitroxic73
Nitroxic73 Jul. 13 at 6:44 PM
$BNTX Zero trades. Following $MRNA though always weaker over time. The issue are zero newsflow and the non-departing goofy CEO who just thinks he can screw the shareholders.hopefully Board of Directors will properly handle it.
1 · Reply
SoYeonPicks
SoYeonPicks Jul. 13 at 12:09 PM
@summerof08 a few here$CAPR $NTLA $VRDN $BNTX $NOW
1 · Reply